WILLIAM MURPHY: Open Payments
NPI 1659305738 · CHATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 48 payments from 15 companies in 2025. Trend: 2023 $1,246 · 2024 $1,626 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $139 |
| GlaxoSmithKline, LLC. | 9 | $139 |
| PFIZER INC. | 5 | $113 |
| ABBVIE INC. | 5 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $80 |
| Novo Nordisk Inc | 3 | $60 |
| Lilly USA, LLC | 3 | $56 |
| QOL Medical, LLC | 2 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: TRELEGY ELLIPTA, Kerendia, OTEZLA, PREVNAR 20, EVENITY, MOUNJARO, Sucraid, VRAYLAR.
Industry payments across NY — which companies pay providers there.
